Bosh sahifaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Yopilish kursi
835,45 ₹
Kunlik diapazon
795,00 ₹ - 836,05 ₹
Yillik diapazon
684,35 ₹ - 1 997,40 ₹
Bozor kapitalizatsiyasi
40,53 mlrd INR
Oʻrtacha hajm
89,92 ming
Narx/foyda
36,53
Dividend daromadliligi
-
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,17 mlrd | -1,47% |
Joriy xarajat | 747,93 mln | 3,12% |
Sof foyda | 207,75 mln | -29,41% |
Sof foyda marjasi | 9,56 | -28,34% |
Har bir ulushga tushum | — | — |
EBITDA | 257,00 mln | -35,44% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,44 mlrd | 384,25% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 12,24 mlrd | — |
Tarqatilgan aksiyalar | 50,67 mln | — |
Narxi/balansdagi bahosi | 3,46 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 3,20% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 207,75 mln | -29,41% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Orchid Pharma Limited is an Indian pharmaceutical chimpanzee based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Tashkil etilgan
1992
Sayt
Xodimlar soni
871
